CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) rose 10.80% to HKD 32.220
Newtimespace News, as of 10:40 on April 30, CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) was quoted at HKD 32.220, up 10.80%. The ETF opened at HKD 31.360, with a high of HKD 32.000 and a low of HKD 31.360. The latest trading volume was 35,300 units, with a turnover of HKD 1.1132 million, and a turnover rate of 5.02%. The latest NAV per unit is HKD 32.526, with a premium rate of -10.59%. The asset size is approximately HKD 22.8144 million, and the total issuance is 701,600 units.
CSOP MicroStrategy Daily (-2x) Inverse Product(07399.HK) is a leveraged inverse ETF product issued by CSOP Asset Management Limited. It aims to deliver returns equivalent to twice the inverse (-2x) of the daily return of the underlying asset (MicroStrategy Incorporated, MSTR). The product's investment strategy is primarily implemented through swap contracts and other financial derivatives. As a high-risk leveraged product, it is suitable for aggressive investors with a clear view on the short-term market direction. However, due to the daily reset mechanism and relatively high management fee, it is not suitable as a long-term holding asset.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Sige New Energy (06656.HK): Change of Board Secretary and Joint Company Secretary, Exemption from Compliance Requirements Granted by HKEX
- ZTHC (00994.HK): Completes Placing of 150 Million New Shares with Net Proceeds of Approximately HK$53 Million
- Henlius(02696.HK): HLX3902 Injection (STEAP1xCD3xCD28 Trispecific Antibody) Gets NMPA Approval for Phase I Clinical Trial in Metastatic Castration-Resistant Prostate Cancer
- CNBM(03323.HK) closed 24.95% higher on Jun 17, leading the Hang Seng Construction Sector
- ITC PROPERTIES(00199.HK) closed 7.32% higher on Jun 17, the Hang Seng Properties Sector saw divergent trends